ROS1 and cancer: This has also been described in other studies,24, 27, 28, 29with suggested explanations as shared risk factors for cancer and ATE (e.g., smoking24), genetic predisposition (e.g., ALK/ROS1 mutations29), and anticancer therapy (e.g., platinum-based chemotherapy28).